Allergy and Infectious Diseases Research in New York
Allergy and Infectious Diseases Research (93.855) awarded $1.8 billion to recipients in New York in 1,155 grants from fiscal 2021 to 2025, 8.3% of the program's national total. Weill Medical College of Cornell University received the most, $279 million.
- Awarded in New York$1.8 billion
- Awards1,155
- Share of the program8.3%
- Rank among states4th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 567 | $330 million |
| FY 2022 | 575 | $409 million |
| FY 2023 | 563 | $333 million |
| FY 2024 | 558 | $335 million |
| FY 2025 | 540 | $390 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Weill Medical College of Cornell University | Colleges and universities | 134 | $279 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 161 | $232 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 130 | $201 million |
| Albert Einstein College of Medicine | Colleges and universities | 85 | $170 million |
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 37 | $157 million |
| New York University | Colleges and universities | 98 | $146 million |
| The Rockefeller University | Colleges and universities | 54 | $119 million |
| University of Rochester | Colleges and universities | 62 | $83.8 million |
| Cornell University | Colleges and universities | 78 | $82.0 million |
| The Research Foundation for the State University of New York | Other | 48 | $46.1 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to New York?
$1.8 billion from fiscal 2021 to 2025, across 1,155 awards. New York ranks 4th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in New York?
The largest recipient is Weill Medical College of Cornell University, with $279 million in 134 awards. Next are The Trustees of Columbia University in the City of New York and Icahn School of Medicine at Mount Sinai.
Can organizations in New York apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund